BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 31980388)

  • 1. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis for substrate recognition and chemical inhibition of oncogenic MAGE ubiquitin ligases.
    Yang SW; Huang X; Lin W; Min J; Miller DJ; Mayasundari A; Rodrigues P; Griffith EC; Gee CT; Li L; Li W; Lee RE; Rankovic Z; Chen T; Potts PR
    Nat Commun; 2020 Oct; 11(1):4931. PubMed ID: 33004795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CstF64-Induced Shortening of the
    Lin A; Ji P; Niu X; Zhao X; Chen Y; Liu W; Liu Y; Fan W; Sun Y; Miao C; Zhang S; Tan W; Lin D; Wagner EJ; Wu C
    Cancer Res; 2021 Nov; 81(22):5638-5651. PubMed ID: 34607841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LINC00921 reduces lung cancer radiosensitivity by destabilizing NUDT21 and driving aberrant MED23 alternative polyadenylation.
    Zhang N; Liu X; Huang L; Zeng J; Ma C; Han L; Li W; Yu J; Yang M
    Cell Rep; 2023 Dec; 42(12):113479. PubMed ID: 37999979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptome 3'end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma.
    Ogorodnikov A; Levin M; Tattikota S; Tokalov S; Hoque M; Scherzinger D; Marini F; Poetsch A; Binder H; Macher-Göppinger S; Probst HC; Tian B; Schaefer M; Lackner KJ; Westermann F; Danckwardt S
    Nat Commun; 2018 Dec; 9(1):5331. PubMed ID: 30552333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
    Ge Y; Huang J; Chen R; Fu Y; Ling T; Ou X; Rong X; Cheng Y; Lin Y; Zhou F; Lu C; Yuan S; Xu A
    PLoS Pathog; 2024 Feb; 20(2):e1012061. PubMed ID: 38416782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shortening of 3' UTRs in most cell types composing tumor tissues implicates alternative polyadenylation in protein metabolism.
    Burri D; Zavolan M
    RNA; 2021 Dec; 27(12):1459-1470. PubMed ID: 34521731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome Analyses of FY Mutants Reveal Its Role in mRNA Alternative Polyadenylation.
    Yu Z; Lin J; Li QQ
    Plant Cell; 2019 Oct; 31(10):2332-2352. PubMed ID: 31427469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huwe1 Sustains Normal Ovarian Epithelial Cell Transformation and Tumor Growth through the Histone H1.3-
    Yang D; Sun B; Zhang X; Cheng D; Yu X; Yan L; Li L; An S; Jiang H; Lasorella A; Iavarone A; Zhang S; Zou F; Zhao X
    Cancer Res; 2017 Sep; 77(18):4773-4784. PubMed ID: 28687618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cleavage factor Im (CFIm) as a regulator of alternative polyadenylation.
    Hardy JG; Norbury CJ
    Biochem Soc Trans; 2016 Aug; 44(4):1051-7. PubMed ID: 27528751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor β1 alters the 3'-UTR of mRNA to promote lung fibrosis.
    Ko J; Mills T; Huang J; Chen NY; Mertens TCJ; Collum SD; Lee G; Xiang Y; Han L; Zhou Y; Lee CG; Elias JA; Jyothula SSK; Rajagopal K; Karmouty-Quintana H; Blackburn MR
    J Biol Chem; 2019 Oct; 294(43):15781-15794. PubMed ID: 31488543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
    Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
    Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of Intronic Polyadenylation by PCF11 Impacts mRNA Expression of Long Genes.
    Wang R; Zheng D; Wei L; Ding Q; Tian B
    Cell Rep; 2019 Mar; 26(10):2766-2778.e6. PubMed ID: 30840896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CPEB1 coordinates alternative 3'-UTR formation with translational regulation.
    Bava FA; Eliscovich C; Ferreira PG; Miñana B; Ben-Dov C; Guigó R; Valcárcel J; Méndez R
    Nature; 2013 Mar; 495(7439):121-5. PubMed ID: 23434754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage factor Im is a key regulator of 3' UTR length.
    Gruber AR; Martin G; Keller W; Zavolan M
    RNA Biol; 2012 Dec; 9(12):1405-12. PubMed ID: 23187700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.